Gene expression in stage-specific populations of Rickettsia prowazekii

普瓦泽基立克次体特定阶段群体的基因表达

基本信息

  • 批准号:
    8606398
  • 负责人:
  • 金额:
    $ 18.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-01-18 至 2015-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Epidemic typhus, one of the most serious bacterial diseases affecting humans, is caused by the louseborne pathogen, Rickettsia prowazekii. Due to the high mortality rate of this disease, the lack of an effective vaccine, and the possibility o aerosol dissemination, R. prowazekii is designated as a select agent and has the potential to pose a severe threat to public health and safety. R. prowazekii is an obligate intracellular, parasitic bacterium that grows only within the cytosol of the host cell, unbounded by a vacuolar membrane. This ability to exploit the intracellular environment and cause human disease provides the basis for our studies designed to elucidate the mechanisms underlying obligate intracellular growth and R. prowazekii virulence. This proposal addresses the identification of critical stage-specific genes that are regulated as a rickettsial infection proceeds from a few rickettsiae per cell to hundreds per cell. A major hurdle in this field is the heterogeneity in the bacterial load within an infected population and the inability to generate synchronous rickettsial cultures. To tackle this problem, we propose to use a fluorescence activated cell sorting (FACS) approach to separate R. prowazekii-infected host cells, based on bacterial load, into distinct stage-specific populations. Using genetically-modified GFP-expressing R. prowazekii, we have demonstrated that FACS can be used to separate R. prowazekii-infected host cells into distinct populations harboring uniform numbers of rickettsiae per cell (population gating). We hypothesize that FACS-based separation of rickettsiae-infected cells will facilitate identification of rickettsial genes that are regulated at specific growth stages and that play key roles in optimizing the growth, virulence, and subsequent spread of this intracellular pathogen. We will address this hypothesis through the following specific aims: In Aim 1 we will identify and separate R. prowazekii-infected host cells into distinct populations according to bacterial load. Rickettsial numbers in isolated populations will be evaluated by microscopy and quantitative PCR. Optimization will include the evaluation of a codon-adapted fluorescent protein. We will evaluate different host cell lines (e.g. vertebrate and arthropod) and a virulent rickettsial strain. The effect of initial host cell infection levels and harvest times wll be examined. In Aim 2 we will identify, at both the transcriptional (gene arrays) and protein level (differential proteomics), genes that are differentially expressed as the rickettsiae transition frm exponential growth to lysis stage. Completion of this project will significantly advance the field, providing an accurate assessment of gene expression at defined stages in the R. prowazekii intracellular growth cycle. This data will lay a foundation for further delineation of molecular mechanisms underlying the infection, intracellular growth, and virulence of R. prowazekii and may reveal new targets for design of novel therapeutics to combat this resourceful and dangerous pathogen.
描述(由申请人提供):流行性斑疹伤寒是影响人类的最严重的细菌性疾病之一,由虱传病原体普瓦泽基立克次体引起。由于该疾病死亡率高、缺乏有效的疫苗以及气溶胶传播的可能性,普罗瓦泽基立克氏菌被指定为选择性病原体,有可能对公众健康和安全构成严重威胁。普罗瓦泽基立克氏菌是一种专性细胞内寄生细菌,仅在宿主细胞的胞浆内生长,不受液泡膜的限制。这种利用细胞内环境并引起人类疾病的能力为我们的研究提供了基础,这些研究旨在阐明专性细胞内生长和普罗瓦泽基菌毒力的机制。该提案致力于鉴定关键阶段特异性基因,这些基因在立克次体感染从每个细胞的几个立克次体发展到每个细胞的数百个立克次体时受到调节。该领域的一个主要障碍是信息的异质性 感染人群中的细菌负荷以及无法产生同步立克次体培养物。为了解决这个问题,我们建议使用荧光激活细胞分选(FACS)方法根据细菌负荷将普罗瓦泽基立克氏菌感染的宿主细胞分离成不同阶段特定的群体。使用基因修饰的表达 GFP 的普罗瓦泽基立克次体,我们证明了 FACS 可用于将普罗瓦泽基立克次体感染的宿主细胞分离成每个细胞含有均匀数量的立克次体的不同群体(群体门控)。我们假设基于 FACS 的立克次体感染细胞分离将有助于鉴定立克次体基因,这些基因在特定生长阶段受到调节,并且在优化这种细胞内病原体的生长、毒力和随后的传播中发挥关键作用。我们将通过以下具体目标来解决这一假设:在目标 1 中,我们将根据细菌负荷识别普罗瓦泽基立克氏菌感染的宿主细胞并将其分成不同的群体。分离群体中的立克次体数量将通过显微镜和定量 PCR 进行评估。优化将包括评估密码子适应荧光蛋白。我们将评估不同的宿主细胞系(例如脊椎动物和节肢动物)和 一种强毒立克次体菌株。将检查初始宿主细胞感染水平和收获时间的影响。在目标 2 中,我们将在转录(基因阵列)和蛋白质水平(差异蛋白质组学)上鉴定当立克次体从指数生长过渡到裂解阶段时差异表达的基因。该项目的完成将显着推进该领域的发展, 提供对 R. prowazekii 细胞内生长周期的特定阶段的基因表达的准确评估。这些数据将为进一步描述普罗瓦泽基菌感染、细胞内生长和毒力的分子机制奠定基础,并可能揭示设计新疗法的新目标,以对抗这种资源丰富且危险的病原体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID WOOD其他文献

DAVID WOOD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID WOOD', 18)}}的其他基金

Gene expression in stage-specific populations of Rickettsia prowazekii
普瓦泽基立克次体特定阶段群体的基因表达
  • 批准号:
    8425189
  • 财政年份:
    2013
  • 资助金额:
    $ 18.56万
  • 项目类别:
SUPPORTING INFLUENZA VACCINE INTRODUCTION IN LOW-MIDDLE INCOME COUNTRIES
支持中低收入国家引进流感疫苗
  • 批准号:
    8331152
  • 财政年份:
    2011
  • 资助金额:
    $ 18.56万
  • 项目类别:
SUPPORTING INFLUENZA VACCINE INTRODUCTION IN LOW-MIDDLE INCOME COUNTRIES
支持中低收入国家引进流感疫苗
  • 批准号:
    8332011
  • 财政年份:
    2011
  • 资助金额:
    $ 18.56万
  • 项目类别:
SUPPORTING INFLUENZA VACCINE INTRODUCTION IN LOW-MIDDLE INCOME COUNTRIES
支持中低收入国家引进流感疫苗
  • 批准号:
    8307704
  • 财政年份:
    2011
  • 资助金额:
    $ 18.56万
  • 项目类别:
GENETIC ANALYSIS OF RICKETTSIA PROWAZEKII
普瓦泽克立克次体的遗传分析
  • 批准号:
    8053672
  • 财政年份:
    2010
  • 资助金额:
    $ 18.56万
  • 项目类别:
Global Analysis of the Rickettsia prowazekii Proteome
普瓦泽基立克次体蛋白质组的整体分析
  • 批准号:
    6837116
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
Global Analysis of the Rickettsia prowazekii Proteome
普瓦泽基立克次体蛋白质组的整体分析
  • 批准号:
    7157623
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
Global Analysis of the Rickettsia prowazekii Proteome
普瓦泽基立克次体蛋白质组的整体分析
  • 批准号:
    7005832
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
Global Analysis of the Rickettsia prowazekii Proteome
普瓦泽基立克次体蛋白质组的整体分析
  • 批准号:
    6672487
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
Global Analysis of the Rickettsia prowazekii Proteome
普瓦泽基立克次体蛋白质组的整体分析
  • 批准号:
    6754378
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:

相似海外基金

AEROSOLS
气雾剂
  • 批准号:
    10101317
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    EU-Funded
AEROSOLS - AIR QUALITY AND HEALTH IMPACT OF PRIMARY SEMI-VOLATILE AND SECONDARY PARTICLES AND THEIR ABATEMENT
气溶胶 - 一次半挥发性颗粒和二次颗粒对空气质量和健康的影响及其消除
  • 批准号:
    10092043
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    EU-Funded
Molecular-level Understanding Of Atmospheric Aerosols (MUOAA 2024); Corsica, France; April 1-5, 2024
对大气气溶胶的分子水平理解(MUOAA 2024);
  • 批准号:
    2332007
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Standard Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
  • 批准号:
    NE/Y000021/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Research Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
  • 批准号:
    NE/Y000358/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Research Grant
Southern Ocean aerosols: sources, sinks and impact on cloud properties
南大洋气溶胶:来源、汇以及对云特性的影响
  • 批准号:
    DP240100389
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Discovery Projects
INvestigating Home water and Aerosols' Links to opportunistic pathogen Exposure (INHALE): do consumer decisions impact pathogen exposure and virulence?
调查家庭用水和气溶胶与机会性病原体暴露(吸入)的联系:消费者的决定是否会影响病原体暴露和毒力?
  • 批准号:
    2326096
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Standard Grant
An AI-driven clinical washbasin unit that automatically disinfects pathogens, reduces aerosols and decreases healthcare-acquired infections by 70%
%20人工智能驱动%20临床%20洗脸盆%20单位%20%20自动%20消毒%20病原体,%20减少%20气溶胶%20和%20减少%20医疗保健获得性%20感染%20by%2070%
  • 批准号:
    83001507
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Innovation Loans
Cloudbusting with JWST: characterising aerosols, aurorae and chemistry in substellar atmospheresto the water cloud regime
使用 JWST 进行云消除:描述水云状态下恒星大气中的气溶胶、极光和化学成分
  • 批准号:
    ST/X001091/1
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Research Grant
Bioactivated Aerosols for Combustion Product Capture
用于燃烧产物捕获的生物活性气溶胶
  • 批准号:
    10080253
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Small Business Research Initiative
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了